slc35a4 Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Target Profile

SLC35A4 antibodies are immunodetection reagents targeting the SLC35A4 protein, a 324-amino acid transmembrane transporter with a molecular weight of ~35 kDa . Key features include:

  • Gene ID: 113829 (Human)

  • UniProt ID: Q96G79

  • Localization: Predominantly Golgi apparatus and endoplasmic reticulum (ER) for the canonical protein , with an alternative isoform (AltSLC35A4) localized to the inner mitochondrial membrane (IMM) .

Canonical SLC35A4 Protein

  • Function: Mediates CDP-ribitol transport into the Golgi, critical for α-dystroglycan glycosylation .

  • Localization: Confirmed in Golgi and ER via immunofluorescence and immunoprecipitation studies .

  • Stress Response: Translationally upregulated during oxidative stress (OS), with a 50–100% increase in protein isoforms under sodium arsenite exposure .

Alternative Isoform (AltSLC35A4)

  • Structure: 103-amino acid microprotein encoded by an upstream open reading frame (uORF) in the SLC35A4 mRNA .

  • Localization: Inner mitochondrial membrane (IMM), confirmed via subcellular fractionation and confocal microscopy .

  • Metabolic Role: Loss of AltSLC35A4 reduces maximal cellular respiration by 30–40%, indicating its role in ATP synthesis .

Western Blot Validation

  • Endogenous Detection: AltSLC35A4 is detectable at ~11 kDa in wild-type cells but absent in CRISPR KO lines .

  • Overexpression: SLC35A4-FLAG overexpression increases ER-associated proteins (e.g., DHCR24, ATP6AP2) by 2–3 fold .

Functional Studies

  • Oxidative Stress Resistance:

    • SLC35A4-KO cells show 40–50% reduced viability under sodium arsenite-induced OS compared to wild-type .

    • Rescue experiments with SLC35A4-3xHA restore viability to 85–90% of wild-type levels .

Technical Challenges and Solutions

  • Low Endogenous Expression: SLC35A4 is difficult to detect via mass spectrometry without overexpression .

  • Antibody Specificity: Custom polyclonal antibodies targeting N-terminal epitopes (e.g., residues 2–60 of AltSLC35A4) are required to avoid cross-reactivity .

Emerging Research Directions

  • Dual-Coding Mechanism: The SLC35A4 gene produces both a Golgi-resident transporter and a mitochondrial microprotein, suggesting a bifunctional role in cellular homeostasis .

  • Therapeutic Potential: SLC35A4 antibodies are being explored as tools to study metabolic diseases linked to glycosylation defects or mitochondrial dysfunction .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
slc35a4 antibody; zgc:153507 antibody; Probable UDP-sugar transporter protein SLC35A4 antibody; Solute carrier family 35 member A4 antibody
Target Names
slc35a4
Uniprot No.

Target Background

Database Links
Protein Families
Nucleotide-sugar transporter family, SLC35A subfamily
Subcellular Location
Golgi apparatus membrane; Multi-pass membrane protein.

Q&A

What is SLC35A4 and why is it significant in biomedical research?

SLC35A4 (Solute Carrier Family 35, Member A4) represents an intriguing research target due to its dual-coding nature. The SLC35A4 gene encodes both the reference protein SLC35A4 and an alternative protein called AltSLC35A4 . Recent studies have demonstrated that SLC35A4 plays a critical role in cellular protection against oxidative stress, with its translational efficiency showing remarkable upregulation during stress conditions . The reference protein has 324 amino acids and the gene contains alternative open reading frames (AltORFs) that produce biologically active alternative proteins . This dual functionality makes SLC35A4 particularly relevant for research into stress response mechanisms and mitochondrial biology.

What experimental applications are SLC35A4 antibodies validated for?

SLC35A4 antibodies have been primarily validated for Western Blotting (WB) applications . When working with these antibodies, researchers should consider that optimal working dilutions need to be determined experimentally for each specific investigation and antibody lot . For detection of the alternative protein AltSLC35A4, specialized protocols may be required, including longer blocking times (overnight rather than 1 hour) and transfer to PVDF membranes instead of nitrocellulose . Immunofluorescence microscopy has also been employed to study the subcellular localization of both SLC35A4 and AltSLC35A4, particularly to confirm mitochondrial localization .

What species reactivity do SLC35A4 antibodies demonstrate?

Commercial SLC35A4 antibodies targeting the middle region (amino acids 143-192) have demonstrated reactivity with several species, including:

SpeciesPredicted Reactivity
Human100%
Guinea Pig85%
Horse87%
Rabbit86%
Saccharomyces cerevisiae (Yeast)100%

This cross-species reactivity is based on sequence homology and predicted epitope conservation . When investigating novel species not listed in product documentation, researchers should align the immunogen sequence with the target species' sequence to predict potential cross-reactivity before experimental validation.

What are the optimal storage and handling conditions for SLC35A4 antibodies?

SLC35A4 antibodies require careful handling to maintain their functionality. For long-term storage, maintain antibodies at -20°C in small aliquots to prevent freeze-thaw cycles that can compromise antibody integrity . For short-term use (up to one week), antibodies may be stored at 2-8°C . Commercial preparations typically contain preservatives such as sodium azide (0.09% w/v) and stabilizers like sucrose (2%), which should be taken into consideration when designing experiments as sodium azide is a hazardous substance that should be handled only by trained personnel . When working with these antibodies, consider that they are typically supplied in liquid format in 1x PBS buffer .

How can researchers validate the specificity of SLC35A4 antibodies?

Validating antibody specificity is crucial for reliable experimental results. For SLC35A4 antibodies, multiple complementary approaches are recommended:

  • CRISPR/Cas9 knockout validation: Generate SLC35A4 knockout cell lines using CRISPR/Cas9 genome editing as performed in recent studies . Compare antibody reactivity between wild-type and knockout cells via Western blot, where true-specific antibodies should show signal absence in knockout lines.

  • Overexpression controls: Transfect cells with tagged SLC35A4 constructs (e.g., SLC35A4-3xHA) to confirm antibody detection of overexpressed protein .

  • Peptide competition assay: Pre-incubate the antibody with its immunizing peptide (for example, the synthetic peptide directed towards the middle region of human SLC35A4) before application in Western blot or immunostaining to confirm binding specificity .

  • Multiple antibody concordance: Compare staining patterns using antibodies targeting different epitopes of SLC35A4 to confirm consistent detection patterns.

These approaches collectively provide strong evidence for antibody specificity when results align across multiple validation methods.

What are the optimized Western blotting protocols for SLC35A4 detection?

Western blotting for SLC35A4 requires protocol optimization based on which form of the protein is being detected:

For reference SLC35A4 protein:

  • Use standard protein extraction methods

  • Transfer to nitrocellulose membrane (0.45 μm) at 1 hour in standard transfer buffer

  • Block with 5% milk in TBS-T (0.1% Tween) for one hour

  • Incubate with primary antibody overnight at 4°C

  • Three 5-minute washes with TBS-T

  • HRP-conjugated secondary antibody incubation for 1 hour

  • Detection using standard ECL reagents

For AltSLC35A4:

  • Requires modified protocol due to small protein size (~11 kDa)

  • Transfer to PVDF membrane (0.22 μm) at 0.15A in 20% methanol for 2 hours

  • Overnight blocking (versus 1 hour for standard proteins)

  • Room temperature incubation with primary antibody (2 hours)

  • Following visualization, densitometric analysis can be performed using ImageJ software, with values normalized to loading controls like actin

What is the subcellular localization of SLC35A4 and AltSLC35A4?

Research has resolved conflicting reports regarding the subcellular localization of SLC35A4 proteins:

AltSLC35A4 has been definitively localized to the inner mitochondrial membrane using a combination of microscopy and biochemical analyses . This finding clarifies previous conflicting reports about its localization. The protein appears to be an integral membrane protein with transmembrane domains .

For visualization of these localizations, researchers typically employ:

  • Fluorescence microscopy with co-localization markers (e.g., mitochondrial markers)

  • Cell fractionation followed by Western blotting

  • Immunoelectron microscopy for high-resolution localization studies

This subcellular distribution information is critical when designing experiments to study the distinct functions of the standard and alternative forms of SLC35A4.

How can researchers differentiate between SLC35A4 and AltSLC35A4 in experimental systems?

Distinguishing between the reference SLC35A4 and AltSLC35A4 proteins is essential for understanding their respective functions:

  • Size-based separation: SLC35A4 is approximately 36 kDa, while AltSLC35A4 is around 11 kDa, allowing differentiation by molecular weight on Western blots .

  • Custom antibodies: Develop epitope-specific antibodies that selectively recognize each protein. Recent research employed a custom polyclonal rat antibody against the N-terminal region (amino acids 2-60) of AltSLC35A4 .

  • Genetic manipulation:

    • AltSLC35A4-specific knockout: Target the alternative open reading frame without disrupting the main SLC35A4 coding sequence

    • SLC35A4-specific manipulation: Design constructs that express only one protein form at a time

  • Subcellular fractionation: Exploit the distinct subcellular localizations, with AltSLC35A4 in the mitochondrial fraction and reference SLC35A4 in other cellular compartments .

A combination of these approaches provides the most reliable differentiation between these protein forms in complex experimental systems.

How does oxidative stress influence SLC35A4 expression and what methodologies best detect these changes?

SLC35A4 exhibits remarkable translational regulation during oxidative stress:

Ribosome profiling studies have revealed that during oxidative stress induced by sodium arsenite, the reference coding sequence of SLC35A4 shows the largest increase in translational efficiency among all cellular mRNAs . This stress-induced upregulation results in the expression of novel SLC35A4 isoforms, which are dependent on the presence of an upstream open reading frame (uORF) .

Interestingly, AltSLC35A4 expression remains unchanged during oxidative stress, suggesting differential regulation of the two protein forms encoded by the same gene .

To study these stress-induced changes, recommended methodologies include:

  • Ribosome profiling: For genome-wide translational efficiency analysis

  • Polysome profiling: To examine stress-induced translational changes

  • Western blotting with isoform-specific detection: To monitor appearance of stress-induced SLC35A4 variants

  • Construct-based studies: Using recombinant SLC35A4-expressing constructs with and without the uORF to study the mechanism of stress-induced isoform expression

These approaches have revealed that SLC35A4's role in the integrated stress response is protective rather than promoting cell death, as knockout cells show enhanced sensitivity to oxidative stress .

What are optimal approaches for analyzing SLC35A4 function in genetic knockout models?

To study SLC35A4 function through knockout models, the following comprehensive methodology has proven effective:

  • CRISPR/Cas9-mediated knockout generation:

    • Design sgRNAs targeting SLC35A4 or AltSLC35A4 specifically

    • Create monoclonal populations and verify edits through PCR and sequencing

    • For SLC35A4, blunt-clone PCR products into vectors (e.g., pBluescript KS) and sequence using Sanger sequencing

    • For AltSLC35A4, analyze clones' allelic sequences using next-generation sequencing (e.g., MiSeq)

  • Functional phenotyping:

    • Cell proliferation assays: Seed equal numbers of cells (e.g., 0.05 × 10^6) and count at 24-hour intervals using automated cell counters

    • Stress susceptibility testing: Challenge cells with oxidative stressors (e.g., sodium arsenite) and assess viability

    • Rescue experiments: Reintroduce wild-type or mutant SLC35A4 constructs to confirm phenotype specificity

  • Molecular characterization:

    • Transcriptomics to identify downstream affected pathways

    • Proteomics to examine global protein changes in knockout cells

    • Metabolomics to detect alterations in cellular metabolism

This multi-dimensional approach allows comprehensive functional characterization of SLC35A4's role in cellular processes, particularly in stress response pathways.

What methods are most effective for generating custom antibodies against SLC35A4 or AltSLC35A4?

Generating effective custom antibodies against SLC35A4 proteins requires careful design:

  • Antigen design considerations:

    • For SLC35A4: The middle region (amino acids 143-192) has proven effective as an immunogen

    • For AltSLC35A4: The N-terminal region (amino acids 2-60) has been successfully used

    • Avoid transmembrane domains that may be poorly immunogenic or inaccessible

    • Consider recombinant expression of protein fragments (as demonstrated with AltSLC35A4's N-terminus in E. coli)

  • Expression and purification strategy:

    • Express antigen fragments as fusion proteins (e.g., with Thioredoxin tag in pRSF-Trx vector)

    • Purify under conditions that maintain native conformation when possible

    • Verify purity by SDS-PAGE before immunization

  • Immunization protocol:

    • Select appropriate host species (rabbit for SLC35A4, rat for AltSLC35A4 have been successful)

    • Consider multiple hosts to increase success probability

    • Implement rigorous validation including knockout cell testing

  • Antibody purification:

    • Affinity purification against the immunizing peptide produces higher specificity

    • Consider cross-adsorption against related proteins to reduce cross-reactivity

A successfully generated antibody should be validated using the methods described in section 2.1 before application in critical experiments.

What technical challenges exist in detecting stress-induced SLC35A4 isoforms?

Researchers face several technical challenges when studying stress-induced SLC35A4 isoforms:

  • Translational complexity:

    • The SLC35A4 mRNA contains upstream ORFs that influence translation initiation during stress

    • Stress conditions induce novel isoforms that may be difficult to distinguish from the reference protein

    • The mechanism of translational upregulation during stress is complex and involves integrated stress response pathways

  • Detection limitations:

    • Standard antibodies may not detect all stress-induced isoforms

    • Small size differences between isoforms require high-resolution gel systems

    • Low abundance of certain isoforms may require enrichment techniques

  • Experimental approaches to overcome these challenges:

    • Use recombinant constructs with and without the uORF to study isoform expression mechanisms

    • Employ gradient gels or Tris-Tricine systems for improved resolution of closely-sized isoforms

    • Combine immunoprecipitation with mass spectrometry for detailed isoform characterization

    • Utilize proximity labeling approaches to identify stress-specific interaction partners

These technical considerations are essential for researchers studying the complex translational regulation of SLC35A4 during cellular stress responses.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.